Mark Powell has been appointed Scientific Manager at Quay Pharma. Dr. Powell will take on wider technical responsibility and seek to further raise the scientific profile of the company. Quay provides solid dosage development covering a broad range of formulation types including lipophilic systems, supported by the development of analytical methods for the recovery of API from lipid systems. Dr. Powell has been with the company for nearly eight years and was previously in charge of the company...